Vir Biotechnology Inc. monthly returns
Vir Biotechnology Inc. has averaged 2.48% per month, positive in 45% of months. Month-by-month returns for Vir Biotechnology Inc. (VIR) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Vir Biotechnology Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -10.9% | |
| Sep 2026 | +2.2% | |
| Aug 2026 | +26.3% | |
| Jul 2026 | -15.0% | |
| Jun 2026 | +6.8% | |
| May 2026 | -6.6% | |
| Apr 2026 | +14.0% | |
| Mar 2026 | -1.4% | |
| Feb 2026 | +22.2% | |
| Jan 2026 | +23.4% | |
| Dec 2025 | -6.1% | |
| Nov 2025 | +7.7% | |
| Oct 2025 | +4.4% | |
| Sep 2025 | +15.6% | |
| Aug 2025 | -2.6% | |
| Jul 2025 | +0.6% | |
| Jun 2025 | +2.0% | |
| May 2025 | -19.3% | |
| Apr 2025 | -5.6% | |
| Mar 2025 | -22.8% | |
| Feb 2025 | -19.3% | |
| Jan 2025 | +41.7% | |
| Dec 2024 | -7.8% | |
| Nov 2024 | +6.3% | |
| Oct 2024 | +0.0% | |
| Sep 2024 | -9.3% | |
| Aug 2024 | -18.7% | |
| Jul 2024 | +14.2% | |
| Jun 2024 | -13.3% | |
| May 2024 | +21.4% | |
| Apr 2024 | -16.5% | |
| Mar 2024 | -9.9% | |
| Feb 2024 | +19.6% | |
| Jan 2024 | -6.6% | |
| Dec 2023 | +6.0% | |
| Nov 2023 | +19.7% | |
| Oct 2023 | -15.4% | |
| Sep 2023 | -26.0% | |
| Aug 2023 | -10.1% | |
| Jul 2023 | -42.6% | |
| Jun 2023 | -8.0% | |
| May 2023 | +6.0% | |
| Apr 2023 | +8.1% | |
| Mar 2023 | +2.1% | |
| Feb 2023 | -22.8% | |
| Jan 2023 | +16.8% | |
| Dec 2022 | -10.3% | |
| Nov 2022 | +28.4% | |
| Oct 2022 | +14.0% | |
| Sep 2022 | -18.8% | |
| Aug 2022 | -14.6% | |
| Jul 2022 | +9.2% | |
| Jun 2022 | -1.3% | |
| May 2022 | +26.8% | |
| Apr 2022 | -20.9% | |
| Mar 2022 | +2.1% | |
| Feb 2022 | -26.6% | |
| Jan 2022 | -18.0% | |
| Dec 2021 | -11.7% | |
| Nov 2021 | +25.7% | |
| Oct 2021 | -13.3% | |
| Sep 2021 | -15.6% | |
| Aug 2021 | +44.6% | |
| Jul 2021 | -24.6% | |
| Jun 2021 | +12.8% | |
| May 2021 | -12.2% | |
| Apr 2021 | -6.9% | |
| Mar 2021 | -18.1% | |
| Feb 2021 | -3.0% | |
| Jan 2021 | +141.0% | |
| Dec 2020 | -16.0% | |
| Nov 2020 | +1.4% | |
| Oct 2020 | -8.4% | |
| Sep 2020 | -15.2% | |
| Aug 2020 | -15.2% | |
| Jul 2020 | +16.6% | |
| Jun 2020 | +19.9% | |
| May 2020 | +12.0% | |
| Apr 2020 | -11.0% | |
| Mar 2020 | -26.3% | |
| Feb 2020 | +74.6% | |
| Jan 2020 | +111.8% | |
| Dec 2019 | +5.2% | |
| Nov 2019 | -15.2% |
Monthly total return (since Nov 2021)#
Vir Biotechnology Inc. returns by calendar month#
Every month of every year since 2020, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -10.91% — 5th of 7 Octobers since 2020 at the last close; the average October returned -3.1%.
| Month | −145%0+145% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +44.3% | +23.4% | 71% | +141.0% 2021 | -18.0% 2022 | |
| Feb | +6.4% | -3.0% | 43% | +74.6% 2020 | -26.6% 2022 | |
| Mar | -10.6% | -9.9% | 29% | +2.1% 2022 | -26.3% 2020 | |
| Apr | -5.5% | -6.9% | 29% | +14.0% 2026 | -20.9% 2022 | |
| May | +4.0% | +6.0% | 57% | +26.8% 2022 | -19.3% 2025 | |
| Jun | +2.7% | +2.0% | 57% | +19.9% 2020 | -13.3% 2024 | |
| Jul | -6.0% | +0.6% | 57% | +16.6% 2020 | -42.6% 2023 | |
| Aug | +1.4% | -10.1% | 29% | +44.6% 2021 | -18.7% 2024 | |
| Sep | -9.6% | -15.2% | 29% | +15.6% 2025 | -26.0% 2023 | |
| Oct | -3.1% | -4.2% | 33% | +14.0% 2022 | -15.4% 2023 | |
| Nov | +14.9% | +13.7% | 100% | +28.4% 2022 | +1.4% 2020 | |
| Dec | -7.6% | -9.1% | 17% | +6.0% 2023 | -16.0% 2020 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from VIR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Vir Biotechnology Inc.'s average monthly return?
- Vir Biotechnology Inc. (VIR) has averaged about 2.48% per month, positive in roughly 45% of months. The best month was Jan 2021 (+141.0%) and the worst was Jul 2023 (-42.6%).